相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combination Effect of Engineered Endolysin EC340 With Antibiotics
Hye-Won Hong et al.
FRONTIERS IN MICROBIOLOGY (2022)
Mycobacteriophages: From Petri dish to patient
Graham F. Hatfull
PLOS PATHOGENS (2022)
Global Tuberculosis Report 2020-Reflections on the Global TB burden, treatment and prevention efforts
Jeremiah Chakaya et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Mycobacteriophages to Treat Tuberculosis: Dream or Delusion?
Andreas H. Diacon et al.
RESPIRATION (2021)
Toward a Phage Cocktail for Tuberculosis: Susceptibility and Tuberculocidal Action of Mycobacteriophages against Diverse Mycobacterium tuberculosis Strains
Carlos A. Guerrero-Bustamante et al.
MBIO (2021)
PLAN-M; Mycobacteriophage Endolysins Fused to Biodegradable Nanobeads Mitigate Mycobacterial Growth in Liquid and on Surfaces
Courtney G. Davies et al.
FRONTIERS IN MICROBIOLOGY (2021)
Exploration of Synergistic Action of Cell Wall-Degrading Enzymes against Mycobacterium tuberculosis
Loes van Schie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Exploring the Enzymatic and Antibacterial Activities of Novel Mycobacteriophage Lysin B Enzymes
Adel Abouhmad et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
How Phages Overcome the Challenges of Drug Resistant Bacteria in Clinical Infections
Majid Taati Moghadam et al.
INFECTION AND DRUG RESISTANCE (2020)
Targeted Pulmonary Delivery of the Green Tea Polyphenol Epigallocatechin Gallate Controls the Growth of Mycobacterium tuberculosis by Enhancing the Autophagy and Suppressing Bacterial Burden
Ankur Sharma et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2020)
Antimicrobial activity of Mycobacteriophage D29 Lysin B during Mycobacterium ulcerans infection
Alexandra G. Fraga et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
Phage Therapy in the Postantibiotic Era
Fernando L. Gordillo Altamirano et al.
CLINICAL MICROBIOLOGY REVIEWS (2019)
Infusion flow related retinal breaks in 25G vitrectomy
Ekta Rishi et al.
ACTA OPHTHALMOLOGICA (2018)
Evaluation of the Efficiency of Lytic Mycobacteriophage D29 on the Model of M-tuberculosis-Infected Macrophage RAW 264 Cell Line
M. B. Lapenkova et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2018)
Anti-mycobacterial activity of some medicinal plants used traditionally by tribes from Madhya Pradesh, India for treating tuberculosis related symptoms
Vivek Kumar Gupta et al.
JOURNAL OF ETHNOPHARMACOLOGY (2018)
Safety Studies of Pneumococcal Endolysins Cpl-1 and Pal
Marek Harhala et al.
VIRUSES-BASEL (2018)
The Ms6 Mycolyl-Arabinogalactan Esterase LysB is Essential for an Efficient Mycobacteriophage-Induced Lysis
Adriano M. Gigante et al.
VIRUSES-BASEL (2017)
A bacteriophage endolysin that eliminates intracellular streptococci
Yang Shen et al.
ELIFE (2016)
Antimycobacterial Activities of Endolysins Derived From a Mycobacteriophage, BTCU-1
Meng-Jiun Lai et al.
MOLECULES (2015)
The Mycobacterial Cell Wall-Peptidoglycan and Arabinogalactan
Luke J. Alderwick et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
Preclinical Safety Evaluation of Intravenously Administered SAL200 Containing the Recombinant Phage Endolysin SAL-1 as a Pharmaceutical Ingredient
Soo Youn Jun et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Molecular Dissection of Phage Endolysin AN INTERDOMAIN INTERACTION CONFERS HOST SPECIFICITY IN LYSIN A OF MYCOBACTERIUM PHAGE D29
Amol Arunrao Pohane et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Comparison of Levofloxacin versus Moxifloxacin for Multidrug-Resistant Tuberculosis
Won-Jung Koh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Novel Bacteriophage Lysin with Broad Lytic Activity Protects against Mixed Infection by Streptococcus pyogenes and Methicillin-Resistant Staphylococcus aureus
Daniel B. Gilmer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Measuring of Mycobacterium tuberculosis growth. A correlation of the optical measurements with colony forming units
Katia Penuelas-Urquides et al.
BRAZILIAN JOURNAL OF MICROBIOLOGY (2013)
HLA-DRB1*1501 and VDR polymorphisms and survival of Mycobacterium tuberculosis in human macrophages exposed to inhalable microparticles
Amit K. Singh et al.
PHARMACOGENOMICS (2013)
Bacteriophage endolysins as novel antimicrobials
Mathias Schmelcher et al.
FUTURE MICROBIOLOGY (2012)
Minimal inhibitory concentrations of first-line drugs of multidrug-resistant tuberculosis isolates
Nicolas Schoenfeld et al.
LUNG INDIA (2012)
Mycobacteriophage Ms6 LysB specifically targets the outer membrane of Mycobacterium smegmatis
Filipa Gil et al.
MICROBIOLOGY-SGM (2010)
Functional relationship between bacterial cell density and the efficacy of antibiotics
Klas I. Udekwu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Mycobacteriophage Lysin B is a novel mycolylarabinogalactan esterase
Kimberly Payne et al.
MOLECULAR MICROBIOLOGY (2009)
Phage lytic enzyme Cpl-1 for antibacterial therapy in experimental pneumococcal meningitis
Denis Grandgirard et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage φMR11
Mohammad Rashel et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis
Neetu Kumra Taneja et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Development of a microdilution method to evaluate Mycobacterium tuberculosis drug susceptibility
E Banfi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Resazurin microtiter assay plate:: Simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis
JC Palomino et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
The global emergency of tuberculosis: what is the cause?
JM Grange et al.
JOURNAL OF THE ROYAL SOCIETY FOR THE PROMOTION OF HEALTH (2002)
分享论文
